Showing results (1371-1380 of 1,430) with videos related to

Sort By:
Pageof 143
Journal of Experimental & Clinical Cancer Research : CR|January 29, 2017
CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signalingDong-Fang Meng, Ping Xie, Li-Xia Peng, et al.
Genes and Immunity|May 5, 2025
Characterizing the immune landscape of tumor-infiltrating lymphocytes in non-small cell lung cancerJin-Guo Liu, Lin Yu, Xian-Ling Guo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2017
Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatmentXiong Zou, Rui You, Huai Liu, et al.
Radiology|August 2, 2016
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines SurvivalLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
Medical Oncology (Northwood, London, England)|August 20, 2013
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Pei-Yu Huang, Lin-Quan Tang, et al.
Nature Communications|February 13, 2025
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemicChenkai Zhao, Tiantian Zhang, Ling Guo, et al.
Plos One|December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Bin Qi, Xiang Guo, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
Cancer Letters|November 5, 2020
LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survivalLi-Xia Peng, Ming-Dian Wang, Ping Xie, et al.
The Lancet. Respiratory Medicine|March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Hui Zheng, Bu-Sen Wang, et al.
Pageof 143